Citadel Advisors’s BiomX PHGE Stock Holding History

Citadel Advisors’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,707	Closed	-$35K	–	13922
2025 Q4	$35K	Buy	18,707 +10,192	+120%	+$68.6K	﹤0.01%	12168
2025 Q3	$84.9K	Buy	+8,515	New	+$78.6K	﹤0.01%	11942
2025 Q1	–	Sell	-1,692	Closed	-$23.5K	–	15320
2024 Q4	$23.5K	Buy	+1,692	New	+$24.1K	﹤0.01%	13069
2024 Q1	–	Sell	-177	Closed	-$9.4K	–	15261
2023 Q4	$9.4K	Buy	+177	New	+$11.1K	﹤0.01%	13154
2023 Q2	–	Sell	-160	Closed	-$9.29K	–	15021
2023 Q1	$9.29K	Buy	+160	New	+$10.1K	﹤0.01%	13592
2022 Q4	–	Sell	-168	Closed	-$11K	–	15306
2022 Q3	$11K	Buy	+168	New	+$21.4K	﹤0.01%	12256

Other funds holding PHGE

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's PHGE Position: Q1 2026 in Review

Citadel Advisors sold out of BiomX (PHGE) in Q1 2026, closing a stake of 18,707 shares — an estimated $35K sold.

Citadel Advisors first reported a position in PHGE in Q3 2022 and held it in 6 quarters. The position peaked at $84.9K in Q3 2025. 13 funds tracked by Wall St. Rank hold PHGE as of Q1 2026.

Citadel Advisors reported no remaining BiomX position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 18,707 BiomX shares in Q1 2026, an estimated $35K.
Citadel Advisors first reported a position in BiomX in Q3 2022 and held it in 6 quarters.
Citadel Advisors's BiomX position peaked at $84.9K in Q3 2025.
13 funds tracked by Wall St. Rank held BiomX as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.